Recent Studies With Omeros’ OMIDRIA To Be Presented at Upcoming Ophthalmology Conferences
Omeros Corporation will be presenting new research revealing the clinical utility of OMIDRIA (phenylephrine and ketorolac injection) 1% / 0.3% and the importance of preventing inflammation and intraoperative pupil constriction ... Read more